A Study of Ranolazine in ALS

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Amyotrophic Lateral Sclerosis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of California, San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Michael Han) · Michael.Han@ucsf.edu · 415-353-7381
    Study coordinator · Neuromuscular.Research@ucsf.edu
    Contact: Principal Investigator (Swathy Chandrashekhar, MD)
  • Mayo Clinic Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Huy B. Tran) · Tran.Huy1@mayo.edu · 904-953-4503
    Contact: Principal Investigator (Bjorn E Oskarsson, MD)
  • University of Kansas Medical Center, Fairway, Kansas, United States

    Contact: Study coordinator (Nick Staudenmier, BS) · nstaudenmier@kumc.edu · 913-945-9922
    Contact: Study coordinator (Katie Lillig, BS) · Kjennens2@kumc.edu · 913-945-9932
    Contact: Principal Investigator (Jeffrey Statland, MD)
  • University of Kansas Medical Center: Wichita, Wichita, Kansas, United States

    Contact: Study coordinator (KUMC CTSU Wichita) · clinicaltrialunit@kumc.edu · 316-293-1833
    Contact: Study coordinator (Hannah Hancock) · hhancock@kumc.edu
    Contact: Principal Investigator (Matthew Byerly, MD)
  • University of Missouri Health Care, Columbia, Missouri, United States

    Contact: Study coordinator (Amanda Heider) · ahmc4@umsystem.edu · 573-884-6852
    Contact: Principal Investigator (William D Arnold, MD)
  • The Ohio State University, Columbus, Ohio, United States

    Contact: Study coordinator (Atchayah Balakrishna) · Atchayah.Balakrishna@osumc.edu
    Contact: Study coordinator (Kaneshia Hives) · Kaneshia.Hives@osumc.edu
    Contact: Principal Investigator (Sarah Heintzman, CNP)
מובילי המחקר
  • Jeffrey Statland, MD

    Principal Investigator

    University of Kansas Medical Center